FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+20.39%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$25.1B
AUM Growth
+$3.39B
(+16%)
Cap. Flow
-$350M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
35.97%
Holding
590
New
73
Increased
186
Reduced
209
Closed
85
Top Buys
| 1 |
Danaher
DHR
|
$173M |
| 2 |
Citigroup
C
|
$129M |
| 3 |
Union Pacific
UNP
|
$108M |
| 4 |
Dollar Tree
DLTR
|
$107M |
| 5 |
Honeywell
HON
|
$99.8M |
Top Sells
| 1 |
Walt Disney
DIS
|
$154M |
| 2 |
UnitedHealth
UNH
|
$141M |
| 3 |
Microsoft
MSFT
|
$140M |
| 4 |
Illumina
ILMN
|
$133M |
| 5 |
Apple
AAPL
|
$129M |
Sector Composition
| 1 | Technology | 27.07% |
| 2 | Healthcare | 23.39% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Communication Services | 10.28% |
| 5 | Financials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
IPG Photonics
IPGP
$3.56B
| $1.51M | 0.01% |
9,967
-227
| -2% | -$34.5K |
|
302
BioMarin Pharmaceuticals
BMRN
$11.1B
| $1.46M | 0.01% |
16,450
-672,286
| -98% | -$59.7M |
|
303
General Dynamics
GD
$86.8B
| $1.46M | 0.01% |
8,628
| – | – |
|
304
Blackstone Mortgage Trust
BXMT
$3.45B
| $1.41M | 0.01% |
40,661
| – | – |
|
305
McDonald's
MCD
$224B
| $1.4M | 0.01% |
7,372
-439,961
| -98% | -$83.6M |
|
306
Medpace
MEDP
$13.7B
| $1.37M | 0.01% |
+23,265
| New | +$1.37M |
|
307
Lamar Advertising Co
LAMR
$13B
| $1.36M | 0.01% |
17,176
+188
| +1% | +$14.9K |
|
308
Bristol-Myers Squibb
BMY
$96B
| $1.35M | 0.01% |
28,323
-182,718
| -87% | -$8.72M |
|
309
Hartford Financial Services
HIG
$37B
| $1.31M | 0.01% |
26,425
| – | – |
|
310
Hamilton Lane
HLNE
$6.36B
| $1.31M | 0.01% |
+30,104
| New | +$1.31M |
|
311
Sempra
SRE
$52.9B
| $1.31M | 0.01% |
20,770
| – | – |
|
312
FibroGen
FGEN
$48.9M
| $1.25M | 0.01% |
920
+120
| +15% | +$163K |
|
313
Amgen
AMGN
$153B
| $1.25M | 0.01% |
6,551
-10,304
| -61% | -$1.96M |
|
|
GAP
314
The Gap, Inc.
GAP
$8.83B
| $1.24M | ﹤0.01% |
47,414
-6,712
| -12% | -$176K |
|
315
Zoetis
ZTS
$67.9B
| $1.24M | ﹤0.01% |
12,288
+6,935
| +130% | +$698K |
|
316
Eaton
ETN
$136B
| $1.2M | ﹤0.01% |
14,859
+3
| +0% | +$242 |
|
317
Gossamer Bio
GOSS
$668M
| $1.19M | ﹤0.01% |
+55,000
| New | +$1.19M |
|
318
AbbVie
ABBV
$375B
| $1.18M | ﹤0.01% |
14,602
-4,555
| -24% | -$367K |
|
|
GBT
319
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.16M | ﹤0.01% |
22,000
-1,000
| -4% | -$52.9K |
|
320
Oneok
OKE
$45.7B
| $1.13M | ﹤0.01% |
16,232
+2,794
| +21% | +$195K |
|
321
Healthpeak Properties
DOC
$12.8B
| $1.13M | ﹤0.01% |
36,000
+20,000
| +125% | +$626K |
|
322
argenx
ARGX
$45.9B
| $1.12M | ﹤0.01% |
+9,000
| New | +$1.12M |
|
|
XLRN
323
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.12M | ﹤0.01% |
+24,000
| New | +$1.12M |
|
324
FMC
FMC
$4.72B
| $1.11M | ﹤0.01% |
14,472
-15,139
| -51% | -$1.16M |
|
325
Equity Lifestyle Properties
ELS
$12B
| $1.1M | ﹤0.01% |
19,294
+150
| +0.8% | +$8.58K |
|